Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18049)

• Formulation Name: Propafenone 225 mg capsule
• Company: Glenmark Pharmaceutials

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Propafenone	(DMPIBJK)	Tachyarrhythmias	BC71	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ferrosoferric oxide	(E00231)	14789	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent